1. At a Glance
TruAlt Bioenergy’s Q2 FY26 results have arrived — and they look like a hangover after an ethanol party. The company, once hailed as India’s largest ethanol producer with a 3.6% national market share, just posted a quarterly loss of ₹38 crore on revenue of ₹115 crore — a massive -70% collapse in sales QoQ and a -103% profit nosedive. Yes, negative. Even the CFO’s calculator must’ve short-circuited trying to justify that.
At ₹458 per share (as of 14 Nov 2025), TruAlt sits with a ₹3,927 crore market cap and a fancy P/E of 30.8, though with this quarter’s loss, “P/E not meaningful” would’ve been kinder. Its ROE at 28.4% and ROCE at 14.2% suggest solid fundamentals — but those are full-year metrics, not quarterly shocks. Debt stands tall at ₹1,546 crore, making the company’s debt-to-equity 1.10, slightly over-energized for a biofuel maker.
Like the Quran says, “Indeed, with hardship comes ease.” (94:6) — hopefully, TruAlt’s ethanol tanks find that ease soon.
The company just signed a ₹2,250 crore MoU with the Andhra Pradesh government to build an 80,000 TPA Sustainable Aviation Fuel (SAF) plant. Ambitious, but after this quarter’s wipeout, investors might be wondering: are we fueling airplanes or burning cash?
2. Introduction
TruAlt Bioenergy Limited’s Q2 FY26 report reads like a screenplay — part ambition, part chaos, full drama. In a sector powered by sugarcane juice and government ethanol blending targets, TruAlt has tried to mix every possible biofuel dream into one chemical cocktail: ethanol, CBG, SAF, ENA, CO₂, even biochemical ventures like Mevalonolactone (which sounds like a Marvel villain).
For a company that calls itself “India’s largest ethanol manufacturer,” it sure picked the wrong quarter to underdeliver — sales plunged from ₹304 crore in Q1 FY26 to just ₹115 crore in Q2 FY26, while operating margins crashed from +14% to -4%. Operating profit fell off a cliff — from ₹42 crore last quarter to a loss of ₹5 crore. That’s not a slowdown; that’s an ethanol engine stalling midair.
But the narrative is far from over. Between its ₹750 crore IPO earlier this year and big-ticket announcements like the SAF project, a Sumitomo JV for compressed biogas, and dual-feedstock upgrades, TruAlt seems to be writing its own Bollywood trilogy: “From Sugar to Jet Fuel: The Ethanol Empire Strikes Back.”
The only question is — will it be a blockbuster or another “budget overrun” sequel?
3. Business Model – WTF Do They Even Do?
TruAlt Bioenergy’s business model is like a buffet at a wedding — everything’s there, but you’re not sure what the main course is.
At its core, TruAlt is a biofuel company. It primarily produces 1G ethanol (first-generation) from molasses, sugar syrup, and sugarcane juice. That’s the part the government loves — because it reduces crude imports. But TruAlt didn’t stop there. It also makes extra neutral alcohol (ENA) for your favorite whisky brand, liquid CO₂, dry ice, power, and even compressed bio-gas (CBG) through its subsidiary, Leafiniti Bioenergy.
Revenue mix tells the story:
- Ethanol – 75% (the core driver)
- ENA – 15% (for the thirsty nation)
- CBG – 1.2% (for green bragging rights)
- CO₂ – 0.3% (for fizzy soda and storage)
- Others – 8.5%
It operates five manufacturing units in Karnataka, with a total installed capacity of 2,000 KLPD and operational capacity of 1,800 KLPD — which alone accounts for 3.6% of India’s ethanol capacity. The company plans to convert 1,300 KLPD into dual-feed plants by FY26, allowing both sugar and grain inputs — because
